世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

認知症治療薬の世界市場に関する洞察と2028年までの予測


Global Dementia Drugs Market Insights and Forecast to 2028

認知症は、人の機能を徐々に低下させる大きな病気群の症状を表す言葉です。 記憶、知性、理性、社会性、そして正常な感情反応とみなされるものが失われることを広く表現している言葉です。認知症は、人の日常生... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年2月11日 US$4,900
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

認知症は、人の機能を徐々に低下させる大きな病気群の症状を表す言葉です。
記憶、知性、理性、社会性、そして正常な感情反応とみなされるものが失われることを広く表現している言葉です。認知症は、人の日常生活に大きな支障をきたします。
アルツハイマー型認知症やその他の一般的な認知症を完治させる薬物療法はありません。しかし、アルツハイマー病の薬には、症状をしばらくの間和らげたり、進行を遅らせることができるものがあります。これらの医薬品は、脳内の基礎疾患の進行を遅らせたり止めたりするものではありません。
本レポートでは、認知症治療薬市場に焦点を当てます。
市場の分析と洞察。認知症治療薬の世界市場
COVID-19の大流行により、世界の認知症治療薬の市場規模は2022年に百万米ドル相当と推定され、2028年にはレビュー期間中にCAGR%で、百万米ドルに再調整されると予測されています。この健康危機による経済変化を十分に考慮し、2021年に認知症治療薬の世界市場の%を占めたMAO阻害剤は、2028年までに百万米ドルの価値を持ち、ポストCOVID-19期間に修正された%のCAGRで成長すると予測されます。一方、病院の薬局セグメントは、この予測期間を通して%CAGRに変更されています。
中国の認知症治療薬の市場規模は2021年に百万米ドル、米国と欧州の認知症治療薬はそれぞれ百万米ドル、百万米ドルとされています。2021年の米国の割合は%、中国と欧州はそれぞれ%、%で、中国の割合は2028年には%に達すると予測され、分析期間を通じてCAGRは%です。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ%、%、%となっています。ヨーロッパの認知症治療薬市場については、ドイツが2028年までに100万ドルに達すると予測され、予測期間中のCAGRは%となっています。
認知症治療薬の世界的な主要メーカーには、Eisai, Inc、Janssen Pharmaceuticals, Inc、Biogen Pharmaceuticals、Forest Laboratories, Inc、Eli Lilly and Company、Novartis AG、Sanofi S.A、AstraZeneca GmbHおよびF. Hoffmann-La Roche等が含まれます。2021年、世界の上位5社は売上高で約 %のシェアを占めています。

世界の認知症治療薬の範囲とセグメント
認知症治療薬市場は、タイプ別と用途別に分類されます。世界の認知症治療薬市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の売上、収益、予測に焦点を当てています。

タイプ別セグメント
MAO阻害剤
コリンエステラーゼ阻害剤
グルタミン酸阻害剤
用途別セグメント
病院薬局
小売店
その他
会社別
エーザイ株式会社
ヤンセン・ファーマシューティカルズ・インク
バイオジェン・ファーマシューティカルズ
フォレスト・ラボラトリーズ・インク
イーライリリー・アンド・カンパニー
ノバルティスAG
サノフィS.A.
アストラゼネカGmbH
F・ホフマン・ラ・ロシュ
メルク・アンド・カンパニー
ヴァリアント・ファーマシューティカル・インターナショナル
ファイザー株式会社
テバ・ファーマシューティカルズ・インダストリー
地域別
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
U.A.E.


ページTOPに戻る


目次

1 Study Coverage
1.1 Dementia Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Dementia Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 MAO Inhibitors
1.2.3 Cholinesterase Inhibitors
1.2.4 Glutamate Inhibitors
1.3 Market by Application
1.3.1 Global Dementia Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dementia Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Dementia Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Dementia Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Dementia Drugs Sales by Region
2.4.1 Global Dementia Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Dementia Drugs by Region (2023-2028)
2.5 Global Dementia Drugs Revenue by Region
2.5.1 Global Dementia Drugs Revenue by Region (2017-2022)
2.5.2 Global Dementia Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Dementia Drugs Sales by Manufacturers
3.1.1 Global Top Dementia Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Dementia Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dementia Drugs in 2021
3.2 Global Dementia Drugs Revenue by Manufacturers
3.2.1 Global Dementia Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Dementia Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Dementia Drugs Revenue in 2021
3.3 Global Dementia Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Dementia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Dementia Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dementia Drugs Sales by Type
4.1.1 Global Dementia Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Dementia Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Dementia Drugs Sales Market Share by Type (2017-2028)
4.2 Global Dementia Drugs Revenue by Type
4.2.1 Global Dementia Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Dementia Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Dementia Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Dementia Drugs Price by Type
4.3.1 Global Dementia Drugs Price by Type (2017-2022)
4.3.2 Global Dementia Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Dementia Drugs Sales by Application
5.1.1 Global Dementia Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Dementia Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Dementia Drugs Sales Market Share by Application (2017-2028)
5.2 Global Dementia Drugs Revenue by Application
5.2.1 Global Dementia Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Dementia Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Dementia Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Dementia Drugs Price by Application
5.3.1 Global Dementia Drugs Price by Application (2017-2022)
5.3.2 Global Dementia Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Dementia Drugs Market Size by Type
6.1.1 North America Dementia Drugs Sales by Type (2017-2028)
6.1.2 North America Dementia Drugs Revenue by Type (2017-2028)
6.2 North America Dementia Drugs Market Size by Application
6.2.1 North America Dementia Drugs Sales by Application (2017-2028)
6.2.2 North America Dementia Drugs Revenue by Application (2017-2028)
6.3 North America Dementia Drugs Market Size by Country
6.3.1 North America Dementia Drugs Sales by Country (2017-2028)
6.3.2 North America Dementia Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Dementia Drugs Market Size by Type
7.1.1 Europe Dementia Drugs Sales by Type (2017-2028)
7.1.2 Europe Dementia Drugs Revenue by Type (2017-2028)
7.2 Europe Dementia Drugs Market Size by Application
7.2.1 Europe Dementia Drugs Sales by Application (2017-2028)
7.2.2 Europe Dementia Drugs Revenue by Application (2017-2028)
7.3 Europe Dementia Drugs Market Size by Country
7.3.1 Europe Dementia Drugs Sales by Country (2017-2028)
7.3.2 Europe Dementia Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Dementia Drugs Market Size by Type
8.1.1 Asia Pacific Dementia Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Dementia Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Dementia Drugs Market Size by Application
8.2.1 Asia Pacific Dementia Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Dementia Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Dementia Drugs Market Size by Region
8.3.1 Asia Pacific Dementia Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Dementia Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Dementia Drugs Market Size by Type
9.1.1 Latin America Dementia Drugs Sales by Type (2017-2028)
9.1.2 Latin America Dementia Drugs Revenue by Type (2017-2028)
9.2 Latin America Dementia Drugs Market Size by Application
9.2.1 Latin America Dementia Drugs Sales by Application (2017-2028)
9.2.2 Latin America Dementia Drugs Revenue by Application (2017-2028)
9.3 Latin America Dementia Drugs Market Size by Country
9.3.1 Latin America Dementia Drugs Sales by Country (2017-2028)
9.3.2 Latin America Dementia Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Dementia Drugs Market Size by Type
10.1.1 Middle East and Africa Dementia Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Dementia Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Dementia Drugs Market Size by Application
10.2.1 Middle East and Africa Dementia Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Dementia Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Dementia Drugs Market Size by Country
10.3.1 Middle East and Africa Dementia Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Dementia Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Eisai, Inc
11.1.1 Eisai, Inc Corporation Information
11.1.2 Eisai, Inc Overview
11.1.3 Eisai, Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Eisai, Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Eisai, Inc Recent Developments
11.2 Janssen Pharmaceuticals, Inc
11.2.1 Janssen Pharmaceuticals, Inc Corporation Information
11.2.2 Janssen Pharmaceuticals, Inc Overview
11.2.3 Janssen Pharmaceuticals, Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Janssen Pharmaceuticals, Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Janssen Pharmaceuticals, Inc Recent Developments
11.3 Biogen Pharmaceuticals
11.3.1 Biogen Pharmaceuticals Corporation Information
11.3.2 Biogen Pharmaceuticals Overview
11.3.3 Biogen Pharmaceuticals Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Biogen Pharmaceuticals Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biogen Pharmaceuticals Recent Developments
11.4 Forest Laboratories, Inc
11.4.1 Forest Laboratories, Inc Corporation Information
11.4.2 Forest Laboratories, Inc Overview
11.4.3 Forest Laboratories, Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Forest Laboratories, Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Forest Laboratories, Inc Recent Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Corporation Information
11.5.2 Eli Lilly and Company Overview
11.5.3 Eli Lilly and Company Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Eli Lilly and Company Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eli Lilly and Company Recent Developments
11.6 Novartis AG
11.6.1 Novartis AG Corporation Information
11.6.2 Novartis AG Overview
11.6.3 Novartis AG Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Novartis AG Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis AG Recent Developments
11.7 Sanofi S.A
11.7.1 Sanofi S.A Corporation Information
11.7.2 Sanofi S.A Overview
11.7.3 Sanofi S.A Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sanofi S.A Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi S.A Recent Developments
11.8 AstraZeneca GmbH
11.8.1 AstraZeneca GmbH Corporation Information
11.8.2 AstraZeneca GmbH Overview
11.8.3 AstraZeneca GmbH Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 AstraZeneca GmbH Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 AstraZeneca GmbH Recent Developments
11.9 F. Hoffmann-La Roche
11.9.1 F. Hoffmann-La Roche Corporation Information
11.9.2 F. Hoffmann-La Roche Overview
11.9.3 F. Hoffmann-La Roche Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 F. Hoffmann-La Roche Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 F. Hoffmann-La Roche Recent Developments
11.10 Merck & Co., Inc
11.10.1 Merck & Co., Inc Corporation Information
11.10.2 Merck & Co., Inc Overview
11.10.3 Merck & Co., Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Merck & Co., Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Merck & Co., Inc Recent Developments
11.11 Valeant Pharmaceutical International
11.11.1 Valeant Pharmaceutical International Corporation Information
11.11.2 Valeant Pharmaceutical International Overview
11.11.3 Valeant Pharmaceutical International Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Valeant Pharmaceutical International Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Valeant Pharmaceutical International Recent Developments
11.12 Pfizer Inc
11.12.1 Pfizer Inc Corporation Information
11.12.2 Pfizer Inc Overview
11.12.3 Pfizer Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Pfizer Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Pfizer Inc Recent Developments
11.13 Teva Pharmaceuticals Industries
11.13.1 Teva Pharmaceuticals Industries Corporation Information
11.13.2 Teva Pharmaceuticals Industries Overview
11.13.3 Teva Pharmaceuticals Industries Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Teva Pharmaceuticals Industries Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Teva Pharmaceuticals Industries Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dementia Drugs Industry Chain Analysis
12.2 Dementia Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dementia Drugs Production Mode & Process
12.4 Dementia Drugs Sales and Marketing
12.4.1 Dementia Drugs Sales Channels
12.4.2 Dementia Drugs Distributors
12.5 Dementia Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Dementia Drugs Industry Trends
13.2 Dementia Drugs Market Drivers
13.3 Dementia Drugs Market Challenges
13.4 Dementia Drugs Market Restraints
14 Key Findings in The Global Dementia Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Dementia is the term used to describe the symptoms of a large group of illnesses that cause a progressive decline in a person’s functioning.
It is a broad term to describe a loss of memory, intellect, rationality, social skills and what would be considered normal emotional reactions. Dementia causes significant impairment in a person’s day to day functioning.
There are no drug treatments that can cure Alzheimer’s disease or any other common type of dementia. However, there are medicines for Alzheimer’s disease that can ease symptoms for a while, or slow down their progression, in some people. These drugs do not slow down or stop the progression of the underlying disease in the brain.
This report focus on Dementia Drugs market.
Market Analysis and Insights: Global Dementia Drugs Market
Due to the COVID-19 pandemic, the global Dementia Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, MAO Inhibitors accounting for % of the Dementia Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
China Dementia Drugs market size is valued at US$ million in 2021, while the US and Europe Dementia Drugs are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Dementia Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Dementia Drugs include Eisai, Inc, Janssen Pharmaceuticals, Inc, Biogen Pharmaceuticals, Forest Laboratories, Inc, Eli Lilly and Company, Novartis AG, Sanofi S.A, AstraZeneca GmbH and F. Hoffmann-La Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Dementia Drugs Scope and Segment
Dementia Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Dementia Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
MAO Inhibitors
Cholinesterase Inhibitors
Glutamate Inhibitors
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others
By Company
Eisai, Inc
Janssen Pharmaceuticals, Inc
Biogen Pharmaceuticals
Forest Laboratories, Inc
Eli Lilly and Company
Novartis AG
Sanofi S.A
AstraZeneca GmbH
F. Hoffmann-La Roche
Merck & Co., Inc
Valeant Pharmaceutical International
Pfizer Inc
Teva Pharmaceuticals Industries
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Dementia Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Dementia Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 MAO Inhibitors
1.2.3 Cholinesterase Inhibitors
1.2.4 Glutamate Inhibitors
1.3 Market by Application
1.3.1 Global Dementia Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dementia Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Dementia Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Dementia Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Dementia Drugs Sales by Region
2.4.1 Global Dementia Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Dementia Drugs by Region (2023-2028)
2.5 Global Dementia Drugs Revenue by Region
2.5.1 Global Dementia Drugs Revenue by Region (2017-2022)
2.5.2 Global Dementia Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Dementia Drugs Sales by Manufacturers
3.1.1 Global Top Dementia Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Dementia Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dementia Drugs in 2021
3.2 Global Dementia Drugs Revenue by Manufacturers
3.2.1 Global Dementia Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Dementia Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Dementia Drugs Revenue in 2021
3.3 Global Dementia Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Dementia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Dementia Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dementia Drugs Sales by Type
4.1.1 Global Dementia Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Dementia Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Dementia Drugs Sales Market Share by Type (2017-2028)
4.2 Global Dementia Drugs Revenue by Type
4.2.1 Global Dementia Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Dementia Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Dementia Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Dementia Drugs Price by Type
4.3.1 Global Dementia Drugs Price by Type (2017-2022)
4.3.2 Global Dementia Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Dementia Drugs Sales by Application
5.1.1 Global Dementia Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Dementia Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Dementia Drugs Sales Market Share by Application (2017-2028)
5.2 Global Dementia Drugs Revenue by Application
5.2.1 Global Dementia Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Dementia Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Dementia Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Dementia Drugs Price by Application
5.3.1 Global Dementia Drugs Price by Application (2017-2022)
5.3.2 Global Dementia Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Dementia Drugs Market Size by Type
6.1.1 North America Dementia Drugs Sales by Type (2017-2028)
6.1.2 North America Dementia Drugs Revenue by Type (2017-2028)
6.2 North America Dementia Drugs Market Size by Application
6.2.1 North America Dementia Drugs Sales by Application (2017-2028)
6.2.2 North America Dementia Drugs Revenue by Application (2017-2028)
6.3 North America Dementia Drugs Market Size by Country
6.3.1 North America Dementia Drugs Sales by Country (2017-2028)
6.3.2 North America Dementia Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Dementia Drugs Market Size by Type
7.1.1 Europe Dementia Drugs Sales by Type (2017-2028)
7.1.2 Europe Dementia Drugs Revenue by Type (2017-2028)
7.2 Europe Dementia Drugs Market Size by Application
7.2.1 Europe Dementia Drugs Sales by Application (2017-2028)
7.2.2 Europe Dementia Drugs Revenue by Application (2017-2028)
7.3 Europe Dementia Drugs Market Size by Country
7.3.1 Europe Dementia Drugs Sales by Country (2017-2028)
7.3.2 Europe Dementia Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Dementia Drugs Market Size by Type
8.1.1 Asia Pacific Dementia Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Dementia Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Dementia Drugs Market Size by Application
8.2.1 Asia Pacific Dementia Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Dementia Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Dementia Drugs Market Size by Region
8.3.1 Asia Pacific Dementia Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Dementia Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Dementia Drugs Market Size by Type
9.1.1 Latin America Dementia Drugs Sales by Type (2017-2028)
9.1.2 Latin America Dementia Drugs Revenue by Type (2017-2028)
9.2 Latin America Dementia Drugs Market Size by Application
9.2.1 Latin America Dementia Drugs Sales by Application (2017-2028)
9.2.2 Latin America Dementia Drugs Revenue by Application (2017-2028)
9.3 Latin America Dementia Drugs Market Size by Country
9.3.1 Latin America Dementia Drugs Sales by Country (2017-2028)
9.3.2 Latin America Dementia Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Dementia Drugs Market Size by Type
10.1.1 Middle East and Africa Dementia Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Dementia Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Dementia Drugs Market Size by Application
10.2.1 Middle East and Africa Dementia Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Dementia Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Dementia Drugs Market Size by Country
10.3.1 Middle East and Africa Dementia Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Dementia Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Eisai, Inc
11.1.1 Eisai, Inc Corporation Information
11.1.2 Eisai, Inc Overview
11.1.3 Eisai, Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Eisai, Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Eisai, Inc Recent Developments
11.2 Janssen Pharmaceuticals, Inc
11.2.1 Janssen Pharmaceuticals, Inc Corporation Information
11.2.2 Janssen Pharmaceuticals, Inc Overview
11.2.3 Janssen Pharmaceuticals, Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Janssen Pharmaceuticals, Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Janssen Pharmaceuticals, Inc Recent Developments
11.3 Biogen Pharmaceuticals
11.3.1 Biogen Pharmaceuticals Corporation Information
11.3.2 Biogen Pharmaceuticals Overview
11.3.3 Biogen Pharmaceuticals Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Biogen Pharmaceuticals Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biogen Pharmaceuticals Recent Developments
11.4 Forest Laboratories, Inc
11.4.1 Forest Laboratories, Inc Corporation Information
11.4.2 Forest Laboratories, Inc Overview
11.4.3 Forest Laboratories, Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Forest Laboratories, Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Forest Laboratories, Inc Recent Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Corporation Information
11.5.2 Eli Lilly and Company Overview
11.5.3 Eli Lilly and Company Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Eli Lilly and Company Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eli Lilly and Company Recent Developments
11.6 Novartis AG
11.6.1 Novartis AG Corporation Information
11.6.2 Novartis AG Overview
11.6.3 Novartis AG Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Novartis AG Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis AG Recent Developments
11.7 Sanofi S.A
11.7.1 Sanofi S.A Corporation Information
11.7.2 Sanofi S.A Overview
11.7.3 Sanofi S.A Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sanofi S.A Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi S.A Recent Developments
11.8 AstraZeneca GmbH
11.8.1 AstraZeneca GmbH Corporation Information
11.8.2 AstraZeneca GmbH Overview
11.8.3 AstraZeneca GmbH Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 AstraZeneca GmbH Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 AstraZeneca GmbH Recent Developments
11.9 F. Hoffmann-La Roche
11.9.1 F. Hoffmann-La Roche Corporation Information
11.9.2 F. Hoffmann-La Roche Overview
11.9.3 F. Hoffmann-La Roche Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 F. Hoffmann-La Roche Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 F. Hoffmann-La Roche Recent Developments
11.10 Merck & Co., Inc
11.10.1 Merck & Co., Inc Corporation Information
11.10.2 Merck & Co., Inc Overview
11.10.3 Merck & Co., Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Merck & Co., Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Merck & Co., Inc Recent Developments
11.11 Valeant Pharmaceutical International
11.11.1 Valeant Pharmaceutical International Corporation Information
11.11.2 Valeant Pharmaceutical International Overview
11.11.3 Valeant Pharmaceutical International Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Valeant Pharmaceutical International Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Valeant Pharmaceutical International Recent Developments
11.12 Pfizer Inc
11.12.1 Pfizer Inc Corporation Information
11.12.2 Pfizer Inc Overview
11.12.3 Pfizer Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Pfizer Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Pfizer Inc Recent Developments
11.13 Teva Pharmaceuticals Industries
11.13.1 Teva Pharmaceuticals Industries Corporation Information
11.13.2 Teva Pharmaceuticals Industries Overview
11.13.3 Teva Pharmaceuticals Industries Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Teva Pharmaceuticals Industries Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Teva Pharmaceuticals Industries Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dementia Drugs Industry Chain Analysis
12.2 Dementia Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dementia Drugs Production Mode & Process
12.4 Dementia Drugs Sales and Marketing
12.4.1 Dementia Drugs Sales Channels
12.4.2 Dementia Drugs Distributors
12.5 Dementia Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Dementia Drugs Industry Trends
13.2 Dementia Drugs Market Drivers
13.3 Dementia Drugs Market Challenges
13.4 Dementia Drugs Market Restraints
14 Key Findings in The Global Dementia Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/12 10:27

160.11 円

174.44 円

209.47 円

ページTOPに戻る